[1] 中华医学会肝病学分会、消化病学分会、感染病学分会. 胆汁淤积性肝病诊断和治疗共识（2015）. 实用肝脏病杂志,2016,19（6）：Ⅰ-Ⅺ.
[2] European Association for the Study of the Liver,EASL Clinical Practice Guidelines:The diagnosis and management of patients with primary biliary cholangitis.J Hepatol,2017,67（1）:145-172.
[3] Jungst C,Berg T,Cheng J,et al. Intrahepatic cholestasis in common chronic liver Diseases. Eur J Clin Invest,2013,43（10）:1069-1083.
[4] Jansen PL,Ghallab A,Vartak N,et al. The ascending pathophysiology of cholestatic liver disease. Hepatology,2017,65（2）:722-738.
[5] Nakazawa T,Notohara K,Tazuma S,et al. The 2016 diagnostic criteria for primary sclerosing cholangitis. J Gastroenterol,2017,52（7）:838-844.
[6] European Association for the Study of the Liver. EASL Clinical Practice Guidelines:management of cholestatic liver diseases. J Hepatol,2009,51（2）:237-267.
[7] Chalasani NP,Hayashi PH,Bonkovsky HL,et al. ACG Clinical Guideline:the diagnosis and management of idiosyncratic drug-
induced liver injury. Am J Gastroenterol,2014,109（7）: 950-966.
[8] Bonkovsky HL,Kleiner DE,Gu J,et al. Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements. Hepatology,2017,65（4）:1267-1277.
[9] 中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南. 临床肝胆病杂志,2015,31（11）:1752-1769.
[10] Roberts EA,Schilsky ML.American Association for Study of Liver Diseases（AASLD）. Diagnosis and treatment of Wilson disease:an update. Hepatology,2008,47（6）:2089-111.
[11] Kova JD,Weber MA. Primary biliary cirrhosis and primary sclerosing cholangitis:an Update on MR imaging findings with recent developments. J Gastrointest Liver Dis,2016,25（4）:517-524.
[12] Oertelt S,Rieger R,Selmi C,et al. A sensitive bead assay for antimitochondrial antibodies:Chipping away at AMA-negative primary biliary cirrhosis. Hepatology,2007,45（3）:659-665.
[13] Liu H,Norman GL,Shums Z,et al. PBC screen:an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun,2010,35（4）:436-442.
[14] Kulecka M,Habior A,Paziewska A,et al. Clinical applicability of whole-exome sequencing exemplified by a study in young adults with the advanced cryptogenic cholestatic liver diseases. Gastroenterol Res Pract,2017,2017:4761962. |
